Abstract
2 min readJournal Article The effect of treatment on serum levels of soluble intercellular adhesion molecules and tumour necrosis factor‐receptor 1 in psoriasis Get access B. Kirby, B. Kirby Dermatopharmacology Unit, Dermatology Centre, Irving Building, University of Manchester, Hope Hospital, Salford, Manchester, M6 8HD, U.K. *ICOS Corporation, Bothell, Washington, U.S.A. †Diabetes Research Institute, Heinrich Heine University, Dusseldorf, GermanyE‐mail: christopher.griffiths@man.ac.uk Search for other works by this author on: Oxford Academic Google Scholar M.J. Boffa, M.J. Boffa Dermatopharmacology Unit, Dermatology Centre, Irving Building, University of Manchester, Hope Hospital, Salford, Manchester, M6 8HD, U.K. *ICOS Corporation, Bothell, Washington, U.S.A. †Diabetes Research Institute, Heinrich Heine University, Dusseldorf, GermanyE‐mail: christopher.griffiths@man.ac.uk Search for other works by this author on: Oxford Academic Google Scholar N. Nayak, N. Nayak Dermatopharmacology Unit, Dermatology Centre, Irving Building, University of Manchester, Hope Hospital, Salford, Manchester, M6 8HD, U.K. *ICOS Corporation, Bothell, Washington, U.S.A. †Diabetes Research Institute, Heinrich Heine University, Dusseldorf, GermanyE‐mail: christopher.griffiths@man.ac.uk Search for other works by this author on: Oxford Academic Google Scholar W.M. Gallatin, W.M. Gallatin Dermatopharmacology Unit, Dermatology Centre, Irving Building, University of Manchester, Hope Hospital, Salford, Manchester, M6 8HD, U.K. *ICOS Corporation, Bothell, Washington, U.S.A. †Diabetes Research Institute, Heinrich Heine University, Dusseldorf, GermanyE‐mail: christopher.griffiths@man.ac.uk Search for other works by this author on: Oxford Academic Google Scholar S. Martin, S. Martin Dermatopharmacology Unit, Dermatology Centre, Irving Building, University of Manchester, Hope Hospital, Salford, Manchester, M6 8HD, U.K. *ICOS Corporation, Bothell, Washington, U.S.A. †Diabetes Research Institute, Heinrich Heine University, Dusseldorf, GermanyE‐mail: christopher.griffiths@man.ac.uk Search for other works by this author on: Oxford Academic Google Scholar C.E.M. Griffiths C.E.M. Griffiths Dermatopharmacology Unit, Dermatology Centre, Irving Building, University of Manchester, Hope Hospital, Salford, Manchester, M6 8HD, U.K. *ICOS Corporation, Bothell, Washington, U.S.A. †Diabetes Research Institute, Heinrich Heine University, Dusseldorf, GermanyE‐mail: christopher.griffiths@man.ac.uk Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, Volume 145, Issue 6, 1 December 2001, Pages 1027–1028, https://doi.org/10.1046/j.1365-2133.2001.04487.x Published: 01 December 2001
Discussion(0)
No comments yet. Be the first to comment.